Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, IPCA Laboratories has enclosed transcript of Conference Call which was held on Wednesday, 14th August, 2024 to discuss the Company’s Q1FY25 earnings and business update.
The above information is a part of company’s filings submitted to BSE.